JAMA Cardiol:主动脉瓣狭窄患者心脏结构和功能改变与TAVR结局的关联

2019-02-27 xiangting MedSci原创

主动脉瓣狭窄分期显示心脏变化的程度与TAVR后全因死亡率之间存在强烈的分级关联。

重度主动脉瓣狭窄引起左心室压力超负荷,从而导致进行性心脏功能障碍,并可延伸到左心室之外。最近一个用于主动脉瓣狭窄的分期系统被提出,该系统可以量化主动脉瓣狭窄结构和功能性心脏改变的程度。

这项研究旨在证实所提出分期系统的可重复性和通过生存分析扩展研究结果,并评估主动脉瓣狭窄分期与经导管主动脉瓣置换术(TAVR)后心源性和非心源性再入院的相关性。

这是一项队列分析,纳入2011年7月1日至2017年1月31日期间在匹兹堡大学医学中心接受TAVR治疗的重度主动脉瓣狭窄患者。排除进行瓣中瓣TAVR手术和基线超声心动图不完整或缺失的患者。从胸外科医师协会数据库收集临床、实验室和手术数据,并通过电子病历回顾进行补充。

主动脉瓣狭窄分期系统基于心脏功能异常的超声心动图标记。分期如下:1期(左心室改变-左心室质量指数增加;二尖瓣舒张早期峰流速与二尖瓣环舒张早期运动速度比值(E/e)>14;左心室射血分数<50%),2期(左心房或二尖瓣改变-左心房容积指数>34mL/m2;中至重度二尖瓣返流;和房颤),3期(肺动脉或三尖瓣改变-肺动脉收缩压≥60mmHg;中至重度三尖瓣返流)和4期(右心室改变-中至重度右心室功能障碍)。

主要结局是TAVR后的全因死亡率。次要结局是全因死亡率和TAVR后全因和心源性再入院的综合。

共纳入689例连续性患者(351例为男性[50.9%],平均[SD]年龄为82.4 [7.6]岁)。1期的患病率为13%;2期,62%;3期,21%;和4期,4%。分期较高的患者胸外科医师学会死亡率预测风险(STS-PROM)所采集的合并症负担较大。尽管调整了STS-PROM,主动脉瓣狭窄分期与全因死亡率之间存在分级关联(2期vs 1期的风险比[HR]:1.37[95%CI,0.81-2.31; P= .25];3期vs 1期:2.24 [95%CI,1.28-3.92; P= .005];4期vs 1期:2.83 [95%CI,1.39-5.76; P= .004])。3期患者TAVR后的心源性(HR,1.84; 95%CI,1.13-3.00; P= .01)和非心源性再入院率均较高。

主动脉瓣狭窄分期显示心脏变化的程度与TAVR后全因死亡率之间存在强烈的分级关联;这样的分期可以改善TAVR患者的患者治疗、风险分层、预后评估以及共同决策。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2086357, encodeId=4d2e208635efa, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3044, encryptionId=134b304456, topicName=AVR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d74253, createdName=wangtianj2007@, createdTime=Thu Aug 01 19:17:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782009, encodeId=a5481e8200953, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Nov 09 01:17:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332620, encodeId=2a7d13326207a, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415472, encodeId=8dc814154e2c6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616013, encodeId=73691616013bc, content=<a href='/topic/show?id=120f516469e' target=_blank style='color:#2F92EE;'>#心脏结构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51646, encryptionId=120f516469e, topicName=心脏结构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41019719888, createdName=12498adam46暂无昵称, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2086357, encodeId=4d2e208635efa, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3044, encryptionId=134b304456, topicName=AVR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d74253, createdName=wangtianj2007@, createdTime=Thu Aug 01 19:17:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782009, encodeId=a5481e8200953, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Nov 09 01:17:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332620, encodeId=2a7d13326207a, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415472, encodeId=8dc814154e2c6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616013, encodeId=73691616013bc, content=<a href='/topic/show?id=120f516469e' target=_blank style='color:#2F92EE;'>#心脏结构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51646, encryptionId=120f516469e, topicName=心脏结构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41019719888, createdName=12498adam46暂无昵称, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2086357, encodeId=4d2e208635efa, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3044, encryptionId=134b304456, topicName=AVR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d74253, createdName=wangtianj2007@, createdTime=Thu Aug 01 19:17:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782009, encodeId=a5481e8200953, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Nov 09 01:17:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332620, encodeId=2a7d13326207a, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415472, encodeId=8dc814154e2c6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616013, encodeId=73691616013bc, content=<a href='/topic/show?id=120f516469e' target=_blank style='color:#2F92EE;'>#心脏结构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51646, encryptionId=120f516469e, topicName=心脏结构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41019719888, createdName=12498adam46暂无昵称, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2086357, encodeId=4d2e208635efa, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3044, encryptionId=134b304456, topicName=AVR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d74253, createdName=wangtianj2007@, createdTime=Thu Aug 01 19:17:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782009, encodeId=a5481e8200953, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Nov 09 01:17:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332620, encodeId=2a7d13326207a, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415472, encodeId=8dc814154e2c6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616013, encodeId=73691616013bc, content=<a href='/topic/show?id=120f516469e' target=_blank style='color:#2F92EE;'>#心脏结构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51646, encryptionId=120f516469e, topicName=心脏结构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41019719888, createdName=12498adam46暂无昵称, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2086357, encodeId=4d2e208635efa, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3044, encryptionId=134b304456, topicName=AVR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d74253, createdName=wangtianj2007@, createdTime=Thu Aug 01 19:17:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782009, encodeId=a5481e8200953, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Nov 09 01:17:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332620, encodeId=2a7d13326207a, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415472, encodeId=8dc814154e2c6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616013, encodeId=73691616013bc, content=<a href='/topic/show?id=120f516469e' target=_blank style='color:#2F92EE;'>#心脏结构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51646, encryptionId=120f516469e, topicName=心脏结构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41019719888, createdName=12498adam46暂无昵称, createdTime=Fri Mar 01 02:17:00 CST 2019, time=2019-03-01, status=1, ipAttribution=)]

相关资讯

Circ: Cardiovasc Inte:经导管主动脉瓣置换术后左心室心肌功能的预后相关因素

左心室心肌做功指数Tei与经导管主动脉瓣置换术后长短期随访期间的临床结局受损有关。

JACC:左心室肥厚不会影响经导管主动脉瓣置换术后的1年临床结局

在接受TAVR的当代患者队列中,根据左心室质量指数和相对壁厚的术前LVH与1年随访的不良结局无关。

Circ: Cardiovasc Inte:根据手术风险一个欧洲经导管主动脉瓣植入队列的1年结局

在临床实践中,三分之二使用SAPIEN 3经导管心脏瓣膜治疗的经导管主动脉瓣植入患者logES<20,但仍被心脏治疗团队认为适合进行经导管主动脉瓣植入,主要是因为年龄较大。

Int J Cardiol:主动脉瓣狭窄患者心肌梗死后双重抗血小板治疗的相关结果

由此可见,当采用DAPT治疗时,AS与MI后出血、复发性心肌梗死和死亡率风险增加有关。在这个高危人群中,可能需要个体化选择抗血小板治疗。

JACC:严重主动脉瓣狭窄的肿瘤患者进行的经导管主动脉瓣置换术

与无癌症患者相比,癌症患者的TAVR与相似的短期预后和较差的长期预后相关。

Heart:瓣膜面积和过高估计的主动脉瓣狭窄风险

由此可见,连续方程推导的AVA正常值小于先前的参考值。在没有该疾病的患者中可以发现低于中度或重度AS的AVA临界值。流量校正指数可能会高估低压力梯度的AS患者,特别是在存在明确的危险因素的情况下。